The Psychiatrist (2008) 32: 88-90. doi: 10.1192/pb.bp.107.015503
© 2008 The Royal College of Psychiatrists
Shared care for treatment of opioid dependence and the new General Medical Services contract
Anna Marie Felice
North West Herts Community Drug and Alcohol Team, Hertfordshire
Partnership Trust, Hemel Hempstead
Christos Kouimtsidis
*Section of Addictive Behaviour, Division of Mental Health,
6th floor, Hunter Wing, St. Georges University of London,
CrammerTerrace, London SW17 0RE, email:
ckouimts{at}sgul.ac.uk
Declaration of interest
None.

Abstract
AIMS AND METHODS
An audit of clients in specialist and shared care services was undertaken
in 2003 and in 2005 to investigate the capacity, quality of prescribed
medication and profile of clients, and to assess the impact of the new General
Medical Services contract on drug misuse treatment.
RESULTS
Capacity in specialist services increased by 55% from 2003 to 2005, but not
in shared care, and type and dosage of prescribed medication improved for
shared care. Profile of clients suggests that stable clients are treated
within shared care.
CLINICAL IMPLICATIONS
Attention should be given in training general practitioners to provide
shared care treatment, increasing the number of clients accepted in shared
care, and considering new treatment models.

Introduction
In 1998, the Government set a target to double the number of
people in
treatment both within statutory and non-statutory
drug services by 2008 and
increase year-on-year the proportion
of individuals misusing drugs
successfully sustaining or completing
treatment
(
Department of Health, 1998).
Changes to treatment
provision in primary care were included in the new
General
Medical Services contract for general practitioners (GPs). The
new
contract formalised the involvement and participation of
GPs providing
substitute-prescribing treatment. This was in
line with government policy that
promoted GPs as having an
important role in modern healthcare for drug users
(
Department of Health, 1998).
Prescribing treatment within primary care services is commonly
known as shared
care. This was defined by the Department of
Health as the joint
participation of GPs and specialists
in the planned delivery of care of
patients with substance
misuse problems informed by an enhanced information
exchange
beyond routine discharge and referral letters
(
Department of Health, 1996).
A
range of models have since developed in the delivery of shared
care. In
Hertfordshire there was not an agreed shared care
prescribing protocol between
primary care and specialist services
until 2004. Shared care for drugs misuse
was in operation in
a number of ways, with or without the support of
specialist
services. Once the new General Medical Services contract for
GPs
came into operation in 2004, it was agreed that shared
care should only be
provided by those GPs on the enhanced services
contract having received
appropriate training and remuneration.
A maximum number of clients had been
agreed for each practice.
The Hertfordshire protocol supports close
collaboration between
primary care and specialist services. This is in line
with
the national framework,
Models of Care for Treatment of Adult Drug
Misusers (
National Treatment Agency
for Substance Misuse, 2002).
The audit reported here was undertaken by specialist services in two
cycles, in October 2003 (before the new General Medical Services contract) and
again in September 2005, with the following aims: (a) to identify which
clients receiving treatment in specialist services were appropriate for shared
care; (b) to assess the impact of the new General Medical Services contract on
drug misuse treatment, including capacity and quality of treatment.

Method
All clients receiving treatment at the time of the audit within
the
specialist services in north west Hertfordshire or in the
shared care scheme
with their respective GPs supported by specialist
services were included in
the sample. Clients in the shared
care scheme unsupported by specialist
services were not included
in the audit. All the information required was
obtained from
the clients case notes using a purposely developed
collection
form. Data collected included prescribing activity; quality
of
treatment provided such as type and dosage of medication,
arrangements for
medication dispensing; clinical characteristics
of clients; and social
characteristics such as current employment
and type of accommodation. In 2003
a narrow approach was used
in identifying clients in specialist services
appropriate for
shared care; only those clients attending services on a
monthly
basis were considered suitable for transfer to shared care.
In 2005
clients identified by the audit to be suitable for
shared care were discussed
with whole team to enable a collective
agreement.

Results
The audit reported no increase in prescribing activity within
primary care
between 2003 and 2005. The clients in shared care
for 2005 were registered
with 14 surgeries, compared with 18
surgeries in 2003. In 2003 there were 31
clients receiving
treatment in shared care and 82 receiving treatment from
specialist
services (total of 113 clients). In 2005 the audit reported
a total
sample group of 157 clients with 30 in shared care
and 127 in treatment with
specialist services - an increase
of 55% within specialist services.
The quality of treatment was assessed by the type and dosage of medication
prescribed for substitute treatment. In 2003, 20% of clients in shared care
were prescribed buprenorphine; this increased to 33% in 2005. In shared care
in 2003, one client received dihydrocodeine tablets, while another received
morphine sulphate tablets. In 2005 there was no prescribing outside guidelines
within shared care (Department of Health
et al, 1999). In specialist services the percentage of
buprenorphine prescribing from 2003 to 2005 increased from 10% to 17%.
From 2003 to 2005 in shared care the mean daily dose for methadone mixture
increased from 28.37 mgs (9-55 mgs) to 40 mgs (8-85 mgs). The mean daily dose
of buprenorphine increased also, from 7 mgs (2-16 mgs) to 8 mgs (0.8-16 mgs).
The methadone mean daily dose for the specialist services group remained the
same, 50.69 mgs (10-100 mgs) in 2003 and 49 mgs (10-100 mgs) in 2005. The mean
daily dose of buprenorphine increased from 6.97 mgs (4-10 mgs) to 9 mgs (2-16
mgs).
For the shared care group in 2003 the majority of clients attended on a
fortnightly basis, while in 2005 50% were attending on a fortnightly basis and
43% were attending every month. None were attending on a weekly basis in 2003;
this was not the case for 2005 with two clients attending on a weekly basis.
In 2003 and 2005 in specialist services 50% of clients attended appointments
on a fortnightly basis, with just over 30% in each of the groups attending on
a weekly basis.
The medication dispensing arrangements for shared care changed from 52% in
2003 collecting their medication on a daily or three times weekly arrangement
to only 17% in 2005 (with none under supervision). The majority of the
remainder were collecting on weekly or fortnightly arrangements. In specialist
services a comparable number, 82% in 2003 and 81% in 2005, were collecting
their medication on a daily (with 7% under supervision) or three times weekly
arrangements, with the rest collecting their medication on twice weekly,
weekly or fortnightly arrangements.
Although 50% of clients in both specialist services and shared care had a
history of injecting behaviour, none of the clients in shared care in either
2003 or 2005 were injecting at the time of the audit. Illicit drug use
(excluding cannabis) was reported by 65% clients in specialist services for
both 2003 and 2005, while in shared care there was a reduction from 52% in
2003 to 34% in 2005.
In shared care, 32% of clients were in paid employment in 2003, and 90% in
2005. In specialist services, the percentage of clients in employment remained
roughly the same (34% in 2003 and 31% in 2005). The vast majority of clients
in both shared care (100%) and specialist services (93%) in 2003 and 2005 were
reported to be living in a type of accommodation rather than homeless.

Discussion
It was expected that the enhanced General Medical Services model
of shared
care would have (a) increased treatment capacity,
which would have had the
effect of increasing treatment options
and choice, and (b) improved the
quality of treatment offered.
It was expected that enhanced training and
appropriate remuneration
would increase the number of GPs providing shared
care, and,
with time, the increased clinical experience and structured
collaboration with specialist services would increase clinicians
confidence, which would lead to increased treatment capacity.
However, the
results of this audit suggested that there was
no increase in activity in
shared care between 2003 and 2005,
with a reduction in number of surgeries
providing shared care
services. Some of the GPs that had been treating people
with
a substance misuse problem decided not to adopt the enhanced
model and
were therefore not eligible under the new contract
to provide shared care
services. Also, after an initial attempt
to enlist GPs on the enhanced model
of prescribing treatment
at the time of the new General Medical Services
contract, this
was not repeated the following year, which could be attributed
to the imposed new costs on primary care trusts to fund this
type of care. As
a result only a low percentage of GPs trained
had actually adopted the
enhanced model. In addition to the
above two factors, the maximum number of
clients per surgery
was not reviewed following the first year of the new
General
Medical Services contract. In 2005 the audit identified 52 clients
in
specialist services who were considered by the clinical
team to be suitable
for shared care. Nine clients were successfully
transferred. Of the remaining
clients, 24 were registered with
surgeries providing shared care treatment,
but the surgeries
had reached their identified limit of clients for shared
care.
These warning signs indicate that the maximum number of clients
per
surgery should be reviewed as confidence and experience
of GPs increases with
time; trained GPs might have to consider
offering shared care treatment to
clients registered with surgeries
elsewhere, and more GPs may be required to
be trained and provide
shared care treatment.
As far as the quality of treatment offered is concerned it is evident that
although the mean dose of prescribed methadone in 2005 still falls below the
national average dosage for maintenance (56.7 mgs)
(Commission for Healthcare Audit and
Inspection, 2006), there was an increase of 41% in shared care
services. However, the audit does not distinguish between maintenance and
reduction regimens. A high percentage of clients on a reduction regimen could
affect the mean daily dose. The mean dosage for buprenorphine for both shared
care and specialist services has also increased. This increase is in line with
Department of Health Clinical Guidelines
(1999), which highlight greater
benefit of maintaining individuals on a daily dose between 60-120 mgs of
methadone (and higher in exceptional cases).
Of note is that in 2005 only medication licensed for use in
substitute-prescribing treatment was in use in the shared care group; this was
not the case in 2003. In 2005 the use of medication outside recommended
guidelines was limited to specialist services and was confined to complicated
presentations and case management.
The lifestyle characteristics for the shared care group demonstrate a level
of stability that is acceptable with the criteria for suitability for shared
care described in the joint working protocol for Hertfordshire (paid
employment and accommodation). This is also supported by the finding that
prescribing appointments and instalments for dispensing medication are in
accordance to expectations. Shared care clients, by virtue of their stability
are often seen fortnightly or monthly with pick-up instalments at twice
weekly, weekly or fortnightly intervals. The audit did not distinguish between
types of accommodation (i.e. rented or owned property, living in a hostel or
with friends), therefore results should be interpreted with caution. However,
employment seems to be an important factor in differentiating the two groups
of clients.
The audit reported here suggests that although the new General Medical
Services contract has not increased treatment capacity within primary care, it
has improved quality of treatment offered, and clients in shared care are more
stable than clients in treatment with specialist services. Further work is
required to develop ways of overcoming identified barriers preventing
successful and effective implementation of the enhanced model of shared care
services.

References
- COMMISSION FOR HEALTHCARE AUDIT AND INSPECTION (2006)
Improving Services for Substance Misuse, a Joint
Review. Commission for Healthcare Audit and
Inspection.
- DEPARTMENT OF HEALTH (1996) Reviewing Shared
Care Arrangements for Drug Misusers. Department of Health Circular. EL
(95) 114. Department of Health.
- DEPARTMENT OF HEALTH (1998) The Task Force
to Review Services for Drug Misusers. Report of an Independent Review of Drug
Treatment Services in England. Department of Health.
- DEPARTMENT OF HEALTH SCOTTISH OFFICE DEPARTMENT OF HEALTH, WELSH
OFFICE DEPARTMENT OF HEALTH AND SOCIAL SERVICES, NORTHERN IRELAND
(1999) Drug Misuse and Dependence: Guidelines on
Clinical Management TSO (The Stationery Office).
- NATIONAL TREATMENT AGENCY FOR SUBSTANCE MISUSE (2002)
Models of Care for Treatment of Adult Drug Misusers. Part 2: Full
Reference Report. National Treatment Agency for Substance
Misuse.